Galapagos | GLPG - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
argenx SE USD 852.2M 369.5M 2025-06
AstraZeneca USD 22.51B 2.78B 2026-03
Biogen USD 358.5M 73.5M 2026-03
Genmab DKK 6M 2M 2025-09
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Merck EUR 2.11B 182M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.46B 99M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
UCB EUR 4.04B 755M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12